Non-muscle invasive bladder cancer is cancer that’s only in the inner lining of your bladder. It hasn’t grown into the muscle wall. Your doctor may also call it superficial bladder cancer, urothelial ...
Source: Getty Images The 2025 EAU guidelines provide updated insights into risk factors, diagnosis, classification, treatment, and follow-up of patients with muscle-invasive and metastatic bladder ...
Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS) The study ...
Nearly 84,000 Americans will receive a bladder cancer diagnosis this year, yet most people remain unaware of the early warning signs that could save their lives. This silent disease often masquerades ...
Inlexzo is approved for BCG-unresponsive NMIBC with CIS, offering a new treatment option for patients with limited alternatives. The SunRISe-1 trial showed an 82% complete response rate, with 51% ...
A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously ...
Bladder Cancer e-Tumor Boards: Case 9: Metastatic Recurrent Urothelial Cancer This case highlights a patient who initially presented with an advanced stage upper tract urothelial tumor, and he ...
a, Schematic illustration of the workflow of the BLOOM assay. b,c, Mechanism of organogel messenger release from the biomarker-degradable bigel film (b) and solvatochromic dye transfer to the organic ...
A 63-year-old man with a 20 pack-year smoking history but who quit 5 years earlier presented initially with gross hematuria. Computed tomography (CT) of the abdomen and pelvic with IV contrast was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results